FDA panel has tie vote on new type 1 diabetes drug
(HealthDay)—A U.S. Food and Drug Administration advisory panel vote on whether to recommend approval of the first oral medication for type 1 diabetes ended in an 8-8 tie Thursday.
Jan 18, 2019
0
6